Our Healthcare News

Bioventus Announces Pricing of Initial Public Offering

DURHAM, North Carolina(GLOBE NEWSWIRE)—Bioventus Inc. (“Bioventus” or the “Company”) today announced the pricing of its initial public offering of 8,000,000 shares of Class A common…  

Feb 10 2021

EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of EYP-1901 for the Treatment of Wet AMD

WATERTOWN, Massachusetts (GLOBE NEWSWIRE)—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with…  

Jan 28 2021

Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio

BOSTON, Massachusetts—PRNewswire—Haemonetics Corporation (NYSE: HAE) (“Haemonetics”), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that…  

Jan 20 2021

EW Healthcare Partners Announces the Closing of EW Healthcare Partners Acquisition Fund with Bioventus as the Core Holding

New York, NY –– EW Healthcare Partners (“EW”), a private equity firm dedicated to making growth equity investments in rapidly growing healthcare companies, announced the…  

Jan 20 2021

Cardiva Medical Announces $45 Million Financing Led by EW Healthcare Partners

Robert S. White Joins Board of Directors

SANTA CLARA, California (GLOBE NEWSWIRE)—Cardiva Medical, Inc, an innovator in the field of vascular closure, today announced the…  

Jul 14 2020

MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings

Equity Financing Led by EW Healthcare Partners and Debt Financing Provided by Hayfin Capital Management. EW Healthcare Partners Managing Director and Co-Founder Martin Sutter and…  

Jul 02 2020

Cobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate

Providing large scale manufacturing capacity for AZD1222

Keele, UK, 16 June 2020: Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO for…  

Jun 16 2020

Xenex LightStrike Robot Destroys SARS-CoV-2 (Coronavirus) in 2 Minutes; First & Only UV Disinfection Technology Proven to Deactivate COVID-19 Virus

San Antonio – April 30, 2020 — SARS-CoV-2 is a global threat for which the world was unprepared. Xenex Disinfection Services announced today that its…  

Apr 30 2020

EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Watertown, MASSACHUSETTS—(GLOBE NEWSWIRE)—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products today announced the pricing of an underwritten…  

Feb 21 2020

View Legacy Fund news >